Irreversible Electroporation (IRE) Followed by Nivolumab in Patients With Metastatic Pancreatic Cancer.

NCT04212026 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped difficult recruitement

Conditions

Metastatic Pancreatic Cancer

Interventions

DRUG: Nivolumab

Sponsor

University Hospital, Basel, Switzerland

Collaborators

[object Object]